Total raised
—
Last: Undisclosed 2025-12
Stage
Seed
Founded
2020
Headcount
6
HQ
Haifa
Sector
Health Tech & Life Sciences
About
Neshima is developing life-saving treatments for severe lung diseases using LiFT™, a patented foam-based delivery platform. LiFT™ enables deep and uniform therapeutic delivery to the alveoli, overcoming the limitations of inhalers, nebulizers, and intravenous treatments. Our lead applications include a regenerative cell therapy for COPD. As a cost-effective PoC we are also developing an ICU-delivered antibiotic treatment for antimicrobial-resistant infections. A fully functional prototype has been tested in large animals. Neshima is targeting a $10 billion U.S. market with a B2B model.
Funding history · 1 round · — total
2025-12
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
patientsmedical-devicesrespiratoryhealthcare-providershospitalsmedical-technologiesdrug-deliverypatent-pending